Cite
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years.
MLA
Schoepf, Isabella C., et al. “Epigenetic Ageing Accelerates before Antiretroviral Therapy and Decelerates after Viral Suppression in People with HIV in Switzerland: A Longitudinal Study over 17 Years.” The Lancet. Healthy Longevity, vol. 4, no. 5, May 2023, pp. e211–18. EBSCOhost, https://doi.org/10.1016/S2666-7568(23)00037-5.
APA
Schoepf, I. C., Esteban-Cantos, A., Thorball, C. W., Rodés, B., Reiss, P., Rodríguez-Centeno, J., Riebensahm, C., Braun, D. L., Marzolini, C., Seneghini, M., Bernasconi, E., Cavassini, M., Buvelot, H., Thurnheer, M. C., Kouyos, R. D., Fellay, J., Günthard, H. F., Arribas, J. R., Ledergerber, B., & Tarr, P. E. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet. Healthy Longevity, 4(5), e211–e218. https://doi.org/10.1016/S2666-7568(23)00037-5
Chicago
Schoepf, Isabella C, Andrés Esteban-Cantos, Christian W Thorball, Berta Rodés, Peter Reiss, Javier Rodríguez-Centeno, Carlotta Riebensahm, et al. 2023. “Epigenetic Ageing Accelerates before Antiretroviral Therapy and Decelerates after Viral Suppression in People with HIV in Switzerland: A Longitudinal Study over 17 Years.” The Lancet. Healthy Longevity 4 (5): e211–18. doi:10.1016/S2666-7568(23)00037-5.